Biotronik - Orsiro Drug Eluting Stent

  Out-of-Stock 

Features:

Drug Eluting Stent

German made

Limus Drug

Bioabsorbable Polymer Matrix

cobolt chromium alloy

 
Notify me when available

  • 0
  • Out stock
  • Free

Biotronik Orsiro Drug Eluting Stent

Orsiro is a one of a kind solution for the treatment of coronary artery stenosis. It has a PROBIO passive coating which encloses the metal stent keeping it from interacting with the encompassing tissue and preventing it from any unnecessary contact. On the other hand, the BIOlute is the active component of the stent. It is made of a combination of bioabsorbable polymer matrix and a Limus drug which makes possible a regulated drug release. Since the BIOlute is bioabsorbable, what remains in a patient is a PROBIO-coated stent.

Orsiro is considered a sixth generation coronary bare metal stent as it uses PRO-Kinetic Energy as its platfrom. It is strong and radiopaque as it is made of a cobolt chromium alloy, allowing thinner struts. Struts as thin as 60 µm makes the stent extra flexible in even the hardest to penetrate.

 

Biotronik - Orsiro Drug Eluting Stent

 

Orsiro has demonstrated consistently low target lesion failure (TLF) in all-comers trials compared to major modern drug-eluding stents (DES).

 

Biotronik - Orsiro Drug Eluting Stent

In a post-hoc analysis of pooled patient-level data from three RCTs, Orsiro achieved a 96.9% probability of superiority on TLF rate versus Xience.

Biotronik - Orsiro Drug Eluting Stent

 

Highly deliverable
Designed for challenging cases, the Orsiro stent system provides better push and easier cross with a lower crossing profile.

 

Biotronik - Orsiro Drug Eluting Stent

Ultrathin 60 µm struts

 

Biotronik - Orsiro Drug Eluting Stent

  

Biotronik - Orsiro Drug Eluting Stent



Reference : 0

Data sheet

  • Switzerland

Specific References

New product



Leave a comment about this product

Write your review

Biotronik - Orsiro Drug Eluting Stent

Write your review